To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference
Disturbances in the system of he¬mostasis and vascular complications is the topical clinical problem, requiring profound study with the development of treatment and prophylaxis algorithm. Thrombus-hemorrhagic complications in patients with chronic myeloproliferative (CMPN) neoplasias are caused by t...
Ausführliche Beschreibung
Autor*in: |
Nikolayenko-Kamyshova T.P. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch ; Ukrainisch |
Erschienen: |
2015 |
---|
Schlagwörter: |
chronic myeloproliferative disorders thrombus-hemorrhagic complications chronic myeloproliferative disorders |
---|
Übergeordnetes Werk: |
In: Medičnì Perspektivi - Dnipro State Medical University, 2019, 20(2015), 3, Seite 144-147 |
---|---|
Übergeordnetes Werk: |
volume:20 ; year:2015 ; number:3 ; pages:144-147 |
Links: |
---|
Katalog-ID: |
DOAJ003690628 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ003690628 | ||
003 | DE-627 | ||
005 | 20230309175802.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230225s2015 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)DOAJ003690628 | ||
035 | |a (DE-599)DOAJ84fa3462e0124a4aa670be092be74e56 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng |a ukr | ||
100 | 0 | |a Nikolayenko-Kamyshova T.P. |e verfasserin |4 aut | |
245 | 1 | 3 | |a To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Disturbances in the system of he¬mostasis and vascular complications is the topical clinical problem, requiring profound study with the development of treatment and prophylaxis algorithm. Thrombus-hemorrhagic complications in patients with chronic myeloproliferative (CMPN) neoplasias are caused by the presence of plethoric and myeloproliferative syndromes, findings of hemogram (level of erythrocytes, thrombocytes, leukocytes, hematocrit index) and hemostasiogram testify to this. A case of thrombus-hemorrhagic complication in a female patient with chronic myeloproliferative neoplasia was considered. Carrying out differential diagnostics requires performing additional investigations: USI, CT with defining of hemostasiogram, hemogram findings, their thorough monitoring when surgical intervention is needed. This diagnosis for the first time was made in conditions of surgical in – patient unit. In pre- and postoperative periods as well as for prevention of vascular complicatients in the patient with CMPN it is necessary to mandarory administer agents which correct hematologic status and rheologic indices. This clinical case was analyzed with the aim to draw doctors’ aftention to complexities in diagnostics and defining treatment tactics for patients with thrombus-hemorrhagic complications: necessity to establish all possible risk factors of vascular events development and to carry out constant hemostasiologic menitoring for preventing lethal outcomes. | ||
650 | 4 | |a chronic myeloproliferative disorders | |
650 | 4 | |a thrombus-hemorrhagic complications chronic myeloproliferative disorders | |
650 | 4 | |a thrombus-hemorrhagic complications | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
773 | 0 | 8 | |i In |t Medičnì Perspektivi |d Dnipro State Medical University, 2019 |g 20(2015), 3, Seite 144-147 |w (DE-627)1760592307 |x 23070404 |7 nnns |
773 | 1 | 8 | |g volume:20 |g year:2015 |g number:3 |g pages:144-147 |
856 | 4 | 0 | |u https://doaj.org/article/84fa3462e0124a4aa670be092be74e56 |z kostenfrei |
856 | 4 | 0 | |u http://medpers.dsma.dp.ua/issues/2015/N3/144-147.pdf |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2307-0404 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2307-0404 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 20 |j 2015 |e 3 |h 144-147 |
author_variant |
n k t nkt |
---|---|
matchkey_str |
article:23070404:2015----::ohpolmfhobseoraicmlctosnhoimeorlfrtvnolsacmlct |
hierarchy_sort_str |
2015 |
publishDate |
2015 |
allfields |
(DE-627)DOAJ003690628 (DE-599)DOAJ84fa3462e0124a4aa670be092be74e56 DE-627 ger DE-627 rakwb eng ukr Nikolayenko-Kamyshova T.P. verfasserin aut To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Disturbances in the system of he¬mostasis and vascular complications is the topical clinical problem, requiring profound study with the development of treatment and prophylaxis algorithm. Thrombus-hemorrhagic complications in patients with chronic myeloproliferative (CMPN) neoplasias are caused by the presence of plethoric and myeloproliferative syndromes, findings of hemogram (level of erythrocytes, thrombocytes, leukocytes, hematocrit index) and hemostasiogram testify to this. A case of thrombus-hemorrhagic complication in a female patient with chronic myeloproliferative neoplasia was considered. Carrying out differential diagnostics requires performing additional investigations: USI, CT with defining of hemostasiogram, hemogram findings, their thorough monitoring when surgical intervention is needed. This diagnosis for the first time was made in conditions of surgical in – patient unit. In pre- and postoperative periods as well as for prevention of vascular complicatients in the patient with CMPN it is necessary to mandarory administer agents which correct hematologic status and rheologic indices. This clinical case was analyzed with the aim to draw doctors’ aftention to complexities in diagnostics and defining treatment tactics for patients with thrombus-hemorrhagic complications: necessity to establish all possible risk factors of vascular events development and to carry out constant hemostasiologic menitoring for preventing lethal outcomes. chronic myeloproliferative disorders thrombus-hemorrhagic complications chronic myeloproliferative disorders thrombus-hemorrhagic complications Medicine R In Medičnì Perspektivi Dnipro State Medical University, 2019 20(2015), 3, Seite 144-147 (DE-627)1760592307 23070404 nnns volume:20 year:2015 number:3 pages:144-147 https://doaj.org/article/84fa3462e0124a4aa670be092be74e56 kostenfrei http://medpers.dsma.dp.ua/issues/2015/N3/144-147.pdf kostenfrei https://doaj.org/toc/2307-0404 Journal toc kostenfrei https://doaj.org/toc/2307-0404 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 20 2015 3 144-147 |
spelling |
(DE-627)DOAJ003690628 (DE-599)DOAJ84fa3462e0124a4aa670be092be74e56 DE-627 ger DE-627 rakwb eng ukr Nikolayenko-Kamyshova T.P. verfasserin aut To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Disturbances in the system of he¬mostasis and vascular complications is the topical clinical problem, requiring profound study with the development of treatment and prophylaxis algorithm. Thrombus-hemorrhagic complications in patients with chronic myeloproliferative (CMPN) neoplasias are caused by the presence of plethoric and myeloproliferative syndromes, findings of hemogram (level of erythrocytes, thrombocytes, leukocytes, hematocrit index) and hemostasiogram testify to this. A case of thrombus-hemorrhagic complication in a female patient with chronic myeloproliferative neoplasia was considered. Carrying out differential diagnostics requires performing additional investigations: USI, CT with defining of hemostasiogram, hemogram findings, their thorough monitoring when surgical intervention is needed. This diagnosis for the first time was made in conditions of surgical in – patient unit. In pre- and postoperative periods as well as for prevention of vascular complicatients in the patient with CMPN it is necessary to mandarory administer agents which correct hematologic status and rheologic indices. This clinical case was analyzed with the aim to draw doctors’ aftention to complexities in diagnostics and defining treatment tactics for patients with thrombus-hemorrhagic complications: necessity to establish all possible risk factors of vascular events development and to carry out constant hemostasiologic menitoring for preventing lethal outcomes. chronic myeloproliferative disorders thrombus-hemorrhagic complications chronic myeloproliferative disorders thrombus-hemorrhagic complications Medicine R In Medičnì Perspektivi Dnipro State Medical University, 2019 20(2015), 3, Seite 144-147 (DE-627)1760592307 23070404 nnns volume:20 year:2015 number:3 pages:144-147 https://doaj.org/article/84fa3462e0124a4aa670be092be74e56 kostenfrei http://medpers.dsma.dp.ua/issues/2015/N3/144-147.pdf kostenfrei https://doaj.org/toc/2307-0404 Journal toc kostenfrei https://doaj.org/toc/2307-0404 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 20 2015 3 144-147 |
allfields_unstemmed |
(DE-627)DOAJ003690628 (DE-599)DOAJ84fa3462e0124a4aa670be092be74e56 DE-627 ger DE-627 rakwb eng ukr Nikolayenko-Kamyshova T.P. verfasserin aut To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Disturbances in the system of he¬mostasis and vascular complications is the topical clinical problem, requiring profound study with the development of treatment and prophylaxis algorithm. Thrombus-hemorrhagic complications in patients with chronic myeloproliferative (CMPN) neoplasias are caused by the presence of plethoric and myeloproliferative syndromes, findings of hemogram (level of erythrocytes, thrombocytes, leukocytes, hematocrit index) and hemostasiogram testify to this. A case of thrombus-hemorrhagic complication in a female patient with chronic myeloproliferative neoplasia was considered. Carrying out differential diagnostics requires performing additional investigations: USI, CT with defining of hemostasiogram, hemogram findings, their thorough monitoring when surgical intervention is needed. This diagnosis for the first time was made in conditions of surgical in – patient unit. In pre- and postoperative periods as well as for prevention of vascular complicatients in the patient with CMPN it is necessary to mandarory administer agents which correct hematologic status and rheologic indices. This clinical case was analyzed with the aim to draw doctors’ aftention to complexities in diagnostics and defining treatment tactics for patients with thrombus-hemorrhagic complications: necessity to establish all possible risk factors of vascular events development and to carry out constant hemostasiologic menitoring for preventing lethal outcomes. chronic myeloproliferative disorders thrombus-hemorrhagic complications chronic myeloproliferative disorders thrombus-hemorrhagic complications Medicine R In Medičnì Perspektivi Dnipro State Medical University, 2019 20(2015), 3, Seite 144-147 (DE-627)1760592307 23070404 nnns volume:20 year:2015 number:3 pages:144-147 https://doaj.org/article/84fa3462e0124a4aa670be092be74e56 kostenfrei http://medpers.dsma.dp.ua/issues/2015/N3/144-147.pdf kostenfrei https://doaj.org/toc/2307-0404 Journal toc kostenfrei https://doaj.org/toc/2307-0404 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 20 2015 3 144-147 |
allfieldsGer |
(DE-627)DOAJ003690628 (DE-599)DOAJ84fa3462e0124a4aa670be092be74e56 DE-627 ger DE-627 rakwb eng ukr Nikolayenko-Kamyshova T.P. verfasserin aut To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Disturbances in the system of he¬mostasis and vascular complications is the topical clinical problem, requiring profound study with the development of treatment and prophylaxis algorithm. Thrombus-hemorrhagic complications in patients with chronic myeloproliferative (CMPN) neoplasias are caused by the presence of plethoric and myeloproliferative syndromes, findings of hemogram (level of erythrocytes, thrombocytes, leukocytes, hematocrit index) and hemostasiogram testify to this. A case of thrombus-hemorrhagic complication in a female patient with chronic myeloproliferative neoplasia was considered. Carrying out differential diagnostics requires performing additional investigations: USI, CT with defining of hemostasiogram, hemogram findings, their thorough monitoring when surgical intervention is needed. This diagnosis for the first time was made in conditions of surgical in – patient unit. In pre- and postoperative periods as well as for prevention of vascular complicatients in the patient with CMPN it is necessary to mandarory administer agents which correct hematologic status and rheologic indices. This clinical case was analyzed with the aim to draw doctors’ aftention to complexities in diagnostics and defining treatment tactics for patients with thrombus-hemorrhagic complications: necessity to establish all possible risk factors of vascular events development and to carry out constant hemostasiologic menitoring for preventing lethal outcomes. chronic myeloproliferative disorders thrombus-hemorrhagic complications chronic myeloproliferative disorders thrombus-hemorrhagic complications Medicine R In Medičnì Perspektivi Dnipro State Medical University, 2019 20(2015), 3, Seite 144-147 (DE-627)1760592307 23070404 nnns volume:20 year:2015 number:3 pages:144-147 https://doaj.org/article/84fa3462e0124a4aa670be092be74e56 kostenfrei http://medpers.dsma.dp.ua/issues/2015/N3/144-147.pdf kostenfrei https://doaj.org/toc/2307-0404 Journal toc kostenfrei https://doaj.org/toc/2307-0404 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 20 2015 3 144-147 |
allfieldsSound |
(DE-627)DOAJ003690628 (DE-599)DOAJ84fa3462e0124a4aa670be092be74e56 DE-627 ger DE-627 rakwb eng ukr Nikolayenko-Kamyshova T.P. verfasserin aut To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Disturbances in the system of he¬mostasis and vascular complications is the topical clinical problem, requiring profound study with the development of treatment and prophylaxis algorithm. Thrombus-hemorrhagic complications in patients with chronic myeloproliferative (CMPN) neoplasias are caused by the presence of plethoric and myeloproliferative syndromes, findings of hemogram (level of erythrocytes, thrombocytes, leukocytes, hematocrit index) and hemostasiogram testify to this. A case of thrombus-hemorrhagic complication in a female patient with chronic myeloproliferative neoplasia was considered. Carrying out differential diagnostics requires performing additional investigations: USI, CT with defining of hemostasiogram, hemogram findings, their thorough monitoring when surgical intervention is needed. This diagnosis for the first time was made in conditions of surgical in – patient unit. In pre- and postoperative periods as well as for prevention of vascular complicatients in the patient with CMPN it is necessary to mandarory administer agents which correct hematologic status and rheologic indices. This clinical case was analyzed with the aim to draw doctors’ aftention to complexities in diagnostics and defining treatment tactics for patients with thrombus-hemorrhagic complications: necessity to establish all possible risk factors of vascular events development and to carry out constant hemostasiologic menitoring for preventing lethal outcomes. chronic myeloproliferative disorders thrombus-hemorrhagic complications chronic myeloproliferative disorders thrombus-hemorrhagic complications Medicine R In Medičnì Perspektivi Dnipro State Medical University, 2019 20(2015), 3, Seite 144-147 (DE-627)1760592307 23070404 nnns volume:20 year:2015 number:3 pages:144-147 https://doaj.org/article/84fa3462e0124a4aa670be092be74e56 kostenfrei http://medpers.dsma.dp.ua/issues/2015/N3/144-147.pdf kostenfrei https://doaj.org/toc/2307-0404 Journal toc kostenfrei https://doaj.org/toc/2307-0404 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 20 2015 3 144-147 |
language |
English Ukrainian |
source |
In Medičnì Perspektivi 20(2015), 3, Seite 144-147 volume:20 year:2015 number:3 pages:144-147 |
sourceStr |
In Medičnì Perspektivi 20(2015), 3, Seite 144-147 volume:20 year:2015 number:3 pages:144-147 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
chronic myeloproliferative disorders thrombus-hemorrhagic complications chronic myeloproliferative disorders thrombus-hemorrhagic complications Medicine R |
isfreeaccess_bool |
true |
container_title |
Medičnì Perspektivi |
authorswithroles_txt_mv |
Nikolayenko-Kamyshova T.P. @@aut@@ |
publishDateDaySort_date |
2015-01-01T00:00:00Z |
hierarchy_top_id |
1760592307 |
id |
DOAJ003690628 |
language_de |
englisch ukrainisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ003690628</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309175802.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ003690628</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ84fa3462e0124a4aa670be092be74e56</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">ukr</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Nikolayenko-Kamyshova T.P.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="3"><subfield code="a">To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Disturbances in the system of he¬mostasis and vascular complications is the topical clinical problem, requiring profound study with the development of treatment and prophylaxis algorithm. Thrombus-hemorrhagic complications in patients with chronic myeloproliferative (CMPN) neoplasias are caused by the presence of plethoric and myeloproliferative syndromes, findings of hemogram (level of erythrocytes, thrombocytes, leukocytes, hematocrit index) and hemostasiogram testify to this. A case of thrombus-hemorrhagic complication in a female patient with chronic myeloproliferative neoplasia was considered. Carrying out differential diagnostics requires performing additional investigations: USI, CT with defining of hemostasiogram, hemogram findings, their thorough monitoring when surgical intervention is needed. This diagnosis for the first time was made in conditions of surgical in – patient unit. In pre- and postoperative periods as well as for prevention of vascular complicatients in the patient with CMPN it is necessary to mandarory administer agents which correct hematologic status and rheologic indices. This clinical case was analyzed with the aim to draw doctors’ aftention to complexities in diagnostics and defining treatment tactics for patients with thrombus-hemorrhagic complications: necessity to establish all possible risk factors of vascular events development and to carry out constant hemostasiologic menitoring for preventing lethal outcomes.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">chronic myeloproliferative disorders</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">thrombus-hemorrhagic complications chronic myeloproliferative disorders</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">thrombus-hemorrhagic complications</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Medičnì Perspektivi</subfield><subfield code="d">Dnipro State Medical University, 2019</subfield><subfield code="g">20(2015), 3, Seite 144-147</subfield><subfield code="w">(DE-627)1760592307</subfield><subfield code="x">23070404</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:20</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:144-147</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/84fa3462e0124a4aa670be092be74e56</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://medpers.dsma.dp.ua/issues/2015/N3/144-147.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2307-0404</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2307-0404</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">20</subfield><subfield code="j">2015</subfield><subfield code="e">3</subfield><subfield code="h">144-147</subfield></datafield></record></collection>
|
author |
Nikolayenko-Kamyshova T.P. |
spellingShingle |
Nikolayenko-Kamyshova T.P. misc chronic myeloproliferative disorders misc thrombus-hemorrhagic complications chronic myeloproliferative disorders misc thrombus-hemorrhagic complications misc Medicine misc R To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference |
authorStr |
Nikolayenko-Kamyshova T.P. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)1760592307 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut |
collection |
DOAJ |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
23070404 |
topic_title |
To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference chronic myeloproliferative disorders thrombus-hemorrhagic complications chronic myeloproliferative disorders thrombus-hemorrhagic complications |
topic |
misc chronic myeloproliferative disorders misc thrombus-hemorrhagic complications chronic myeloproliferative disorders misc thrombus-hemorrhagic complications misc Medicine misc R |
topic_unstemmed |
misc chronic myeloproliferative disorders misc thrombus-hemorrhagic complications chronic myeloproliferative disorders misc thrombus-hemorrhagic complications misc Medicine misc R |
topic_browse |
misc chronic myeloproliferative disorders misc thrombus-hemorrhagic complications chronic myeloproliferative disorders misc thrombus-hemorrhagic complications misc Medicine misc R |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Medičnì Perspektivi |
hierarchy_parent_id |
1760592307 |
hierarchy_top_title |
Medičnì Perspektivi |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)1760592307 |
title |
To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference |
ctrlnum |
(DE-627)DOAJ003690628 (DE-599)DOAJ84fa3462e0124a4aa670be092be74e56 |
title_full |
To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference |
author_sort |
Nikolayenko-Kamyshova T.P. |
journal |
Medičnì Perspektivi |
journalStr |
Medičnì Perspektivi |
lang_code |
eng ukr |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2015 |
contenttype_str_mv |
txt |
container_start_page |
144 |
author_browse |
Nikolayenko-Kamyshova T.P. |
container_volume |
20 |
format_se |
Elektronische Aufsätze |
author-letter |
Nikolayenko-Kamyshova T.P. |
title_sort |
the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. complicated diagnosis. clinical case conference |
title_auth |
To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference |
abstract |
Disturbances in the system of he¬mostasis and vascular complications is the topical clinical problem, requiring profound study with the development of treatment and prophylaxis algorithm. Thrombus-hemorrhagic complications in patients with chronic myeloproliferative (CMPN) neoplasias are caused by the presence of plethoric and myeloproliferative syndromes, findings of hemogram (level of erythrocytes, thrombocytes, leukocytes, hematocrit index) and hemostasiogram testify to this. A case of thrombus-hemorrhagic complication in a female patient with chronic myeloproliferative neoplasia was considered. Carrying out differential diagnostics requires performing additional investigations: USI, CT with defining of hemostasiogram, hemogram findings, their thorough monitoring when surgical intervention is needed. This diagnosis for the first time was made in conditions of surgical in – patient unit. In pre- and postoperative periods as well as for prevention of vascular complicatients in the patient with CMPN it is necessary to mandarory administer agents which correct hematologic status and rheologic indices. This clinical case was analyzed with the aim to draw doctors’ aftention to complexities in diagnostics and defining treatment tactics for patients with thrombus-hemorrhagic complications: necessity to establish all possible risk factors of vascular events development and to carry out constant hemostasiologic menitoring for preventing lethal outcomes. |
abstractGer |
Disturbances in the system of he¬mostasis and vascular complications is the topical clinical problem, requiring profound study with the development of treatment and prophylaxis algorithm. Thrombus-hemorrhagic complications in patients with chronic myeloproliferative (CMPN) neoplasias are caused by the presence of plethoric and myeloproliferative syndromes, findings of hemogram (level of erythrocytes, thrombocytes, leukocytes, hematocrit index) and hemostasiogram testify to this. A case of thrombus-hemorrhagic complication in a female patient with chronic myeloproliferative neoplasia was considered. Carrying out differential diagnostics requires performing additional investigations: USI, CT with defining of hemostasiogram, hemogram findings, their thorough monitoring when surgical intervention is needed. This diagnosis for the first time was made in conditions of surgical in – patient unit. In pre- and postoperative periods as well as for prevention of vascular complicatients in the patient with CMPN it is necessary to mandarory administer agents which correct hematologic status and rheologic indices. This clinical case was analyzed with the aim to draw doctors’ aftention to complexities in diagnostics and defining treatment tactics for patients with thrombus-hemorrhagic complications: necessity to establish all possible risk factors of vascular events development and to carry out constant hemostasiologic menitoring for preventing lethal outcomes. |
abstract_unstemmed |
Disturbances in the system of he¬mostasis and vascular complications is the topical clinical problem, requiring profound study with the development of treatment and prophylaxis algorithm. Thrombus-hemorrhagic complications in patients with chronic myeloproliferative (CMPN) neoplasias are caused by the presence of plethoric and myeloproliferative syndromes, findings of hemogram (level of erythrocytes, thrombocytes, leukocytes, hematocrit index) and hemostasiogram testify to this. A case of thrombus-hemorrhagic complication in a female patient with chronic myeloproliferative neoplasia was considered. Carrying out differential diagnostics requires performing additional investigations: USI, CT with defining of hemostasiogram, hemogram findings, their thorough monitoring when surgical intervention is needed. This diagnosis for the first time was made in conditions of surgical in – patient unit. In pre- and postoperative periods as well as for prevention of vascular complicatients in the patient with CMPN it is necessary to mandarory administer agents which correct hematologic status and rheologic indices. This clinical case was analyzed with the aim to draw doctors’ aftention to complexities in diagnostics and defining treatment tactics for patients with thrombus-hemorrhagic complications: necessity to establish all possible risk factors of vascular events development and to carry out constant hemostasiologic menitoring for preventing lethal outcomes. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
container_issue |
3 |
title_short |
To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference |
url |
https://doaj.org/article/84fa3462e0124a4aa670be092be74e56 http://medpers.dsma.dp.ua/issues/2015/N3/144-147.pdf https://doaj.org/toc/2307-0404 |
remote_bool |
true |
ppnlink |
1760592307 |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
up_date |
2024-07-03T19:31:12.668Z |
_version_ |
1803587496358969344 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ003690628</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309175802.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ003690628</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ84fa3462e0124a4aa670be092be74e56</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">ukr</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Nikolayenko-Kamyshova T.P.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="3"><subfield code="a">To the problem of thrombus-hemorrhagic complications in chronic myeloproliferative neoplasias. Complicated diagnosis. Clinical case conference</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Disturbances in the system of he¬mostasis and vascular complications is the topical clinical problem, requiring profound study with the development of treatment and prophylaxis algorithm. Thrombus-hemorrhagic complications in patients with chronic myeloproliferative (CMPN) neoplasias are caused by the presence of plethoric and myeloproliferative syndromes, findings of hemogram (level of erythrocytes, thrombocytes, leukocytes, hematocrit index) and hemostasiogram testify to this. A case of thrombus-hemorrhagic complication in a female patient with chronic myeloproliferative neoplasia was considered. Carrying out differential diagnostics requires performing additional investigations: USI, CT with defining of hemostasiogram, hemogram findings, their thorough monitoring when surgical intervention is needed. This diagnosis for the first time was made in conditions of surgical in – patient unit. In pre- and postoperative periods as well as for prevention of vascular complicatients in the patient with CMPN it is necessary to mandarory administer agents which correct hematologic status and rheologic indices. This clinical case was analyzed with the aim to draw doctors’ aftention to complexities in diagnostics and defining treatment tactics for patients with thrombus-hemorrhagic complications: necessity to establish all possible risk factors of vascular events development and to carry out constant hemostasiologic menitoring for preventing lethal outcomes.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">chronic myeloproliferative disorders</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">thrombus-hemorrhagic complications chronic myeloproliferative disorders</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">thrombus-hemorrhagic complications</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Medičnì Perspektivi</subfield><subfield code="d">Dnipro State Medical University, 2019</subfield><subfield code="g">20(2015), 3, Seite 144-147</subfield><subfield code="w">(DE-627)1760592307</subfield><subfield code="x">23070404</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:20</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:144-147</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/84fa3462e0124a4aa670be092be74e56</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://medpers.dsma.dp.ua/issues/2015/N3/144-147.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2307-0404</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2307-0404</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">20</subfield><subfield code="j">2015</subfield><subfield code="e">3</subfield><subfield code="h">144-147</subfield></datafield></record></collection>
|
score |
7.401535 |